Global Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Parkinson's Disease (PD) Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Dopamine Agonist
  • 1.2.3 Monoamine Oxidase Inhibitors
  • 1.2.4 Acetylcholinesterase Inhibitors
  • 1.2.5 Glutamate Inhibitors
• 1.3 Market by Application
  • 1.3.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Family
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Parkinson's Disease (PD) Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Parkinson's Disease (PD) Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Parkinson's Disease (PD) Drugs Sales by Region
  • 2.4.1 Global Parkinson's Disease (PD) Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Parkinson's Disease (PD) Drugs by Region (2023-2028)
• 2.5 Global Parkinson's Disease (PD) Drugs Revenue by Region
  • 2.5.1 Global Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Parkinson's Disease (PD) Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers
  • 3.1.1 Global Top Parkinson's Disease (PD) Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinson's Disease (PD) Drugs in 2021
• 3.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers
  • 3.2.1 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Parkinson's Disease (PD) Drugs Revenue in 2021
• 3.3 Global Parkinson's Disease (PD) Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Parkinson's Disease (PD) Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Parkinson's Disease (PD) Drugs Sales by Type
  • 4.1.1 Global Parkinson's Disease (PD) Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Parkinson's Disease (PD) Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Parkinson's Disease (PD) Drugs Revenue by Type
  • 4.2.1 Global Parkinson's Disease (PD) Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Parkinson's Disease (PD) Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Parkinson's Disease (PD) Drugs Price by Type
  • 4.3.1 Global Parkinson's Disease (PD) Drugs Price by Type (2017-2022)
  • 4.3.2 Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Parkinson's Disease (PD) Drugs Sales by Application
  • 5.1.1 Global Parkinson's Disease (PD) Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Parkinson's Disease (PD) Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Parkinson's Disease (PD) Drugs Revenue by Application
  • 5.2.1 Global Parkinson's Disease (PD) Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Parkinson's Disease (PD) Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Parkinson's Disease (PD) Drugs Price by Application
  • 5.3.1 Global Parkinson's Disease (PD) Drugs Price by Application (2017-2022)
  • 5.3.2 Global Parkinson's Disease (PD) Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Parkinson's Disease (PD) Drugs Market Size by Type
  • 6.1.1 North America Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
• 6.2 North America Parkinson's Disease (PD) Drugs Market Size by Application
  • 6.2.1 North America Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
• 6.3 North America Parkinson's Disease (PD) Drugs Market Size by Country
  • 6.3.1 North America Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Parkinson's Disease (PD) Drugs Market Size by Type
  • 7.1.1 Europe Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
• 7.2 Europe Parkinson's Disease (PD) Drugs Market Size by Application
  • 7.2.1 Europe Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
• 7.3 Europe Parkinson's Disease (PD) Drugs Market Size by Country
  • 7.3.1 Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Type
  • 8.1.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Application
  • 8.2.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region
  • 8.3.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Parkinson's Disease (PD) Drugs Market Size by Type
  • 9.1.1 Latin America Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Parkinson's Disease (PD) Drugs Market Size by Application
  • 9.2.1 Latin America Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Parkinson's Disease (PD) Drugs Market Size by Country
  • 9.3.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Boehringer Ingelheim
  • 11.1.1 Boehringer Ingelheim Corporation Information
  • 11.1.2 Boehringer Ingelheim Overview
  • 11.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Boehringer Ingelheim Recent Developments
• 11.2 GlaxoSmithKline
  • 11.2.1 GlaxoSmithKline Corporation Information
  • 11.2.2 GlaxoSmithKline Overview
  • 11.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 GlaxoSmithKline Recent Developments
• 11.3 Novartis
  • 11.3.1 Novartis Corporation Information
  • 11.3.2 Novartis Overview
  • 11.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Novartis Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Novartis Recent Developments
• 11.4 Teva Pharmaceutical Industries
  • 11.4.1 Teva Pharmaceutical Industries Corporation Information
  • 11.4.2 Teva Pharmaceutical Industries Overview
  • 11.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Teva Pharmaceutical Industries Recent Developments
• 11.5 AbbVie
  • 11.5.1 AbbVie Corporation Information
  • 11.5.2 AbbVie Overview
  • 11.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 AbbVie Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 AbbVie Recent Developments
• 11.6 Abital Pharma
  • 11.6.1 Abital Pharma Corporation Information
  • 11.6.2 Abital Pharma Overview
  • 11.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Abital Pharma Recent Developments
• 11.7 Addex Therapeutics
  • 11.7.1 Addex Therapeutics Corporation Information
  • 11.7.2 Addex Therapeutics Overview
  • 11.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Addex Therapeutics Recent Developments
• 11.8 Biogen
  • 11.8.1 Biogen Corporation Information
  • 11.8.2 Biogen Overview
  • 11.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Biogen Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Biogen Recent Developments
• 11.9 Eisai
  • 11.9.1 Eisai Corporation Information
  • 11.9.2 Eisai Overview
  • 11.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Eisai Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Eisai Recent Developments
• 11.10 Eli Lilly
  • 11.10.1 Eli Lilly Corporation Information
  • 11.10.2 Eli Lilly Overview
  • 11.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Eli Lilly Recent Developments
• 11.11 F. Hoffmann-La Roche
  • 11.11.1 F. Hoffmann-La Roche Corporation Information
  • 11.11.2 F. Hoffmann-La Roche Overview
  • 11.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 F. Hoffmann-La Roche Recent Developments
• 11.12 H. Lundbeck
  • 11.12.1 H. Lundbeck Corporation Information
  • 11.12.2 H. Lundbeck Overview
  • 11.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 H. Lundbeck Recent Developments
• 11.13 Impax Laboratories
  • 11.13.1 Impax Laboratories Corporation Information
  • 11.13.2 Impax Laboratories Overview
  • 11.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Impax Laboratories Recent Developments
• 11.14 Kyowa Hakko Kirin
  • 11.14.1 Kyowa Hakko Kirin Corporation Information
  • 11.14.2 Kyowa Hakko Kirin Overview
  • 11.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Kyowa Hakko Kirin Recent Developments
• 11.15 Otsuka Pharmaceutical
  • 11.15.1 Otsuka Pharmaceutical Corporation Information
  • 11.15.2 Otsuka Pharmaceutical Overview
  • 11.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Otsuka Pharmaceutical Recent Developments
• 11.16 Pfizer
  • 11.16.1 Pfizer Corporation Information
  • 11.16.2 Pfizer Overview
  • 11.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.16.4 Pfizer Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Pfizer Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
• 12.2 Parkinson's Disease (PD) Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Parkinson's Disease (PD) Drugs Production Mode & Process
• 12.4 Parkinson's Disease (PD) Drugs Sales and Marketing
  • 12.4.1 Parkinson's Disease (PD) Drugs Sales Channels
  • 12.4.2 Parkinson's Disease (PD) Drugs Distributors
• 12.5 Parkinson's Disease (PD) Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Parkinson's Disease (PD) Drugs Industry Trends
• 13.2 Parkinson's Disease (PD) Drugs Market Drivers
• 13.3 Parkinson's Disease (PD) Drugs Market Challenges
• 13.4 Parkinson's Disease (PD) Drugs Market Restraints

14 Key Findings in The Global Parkinson's Disease (PD) Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Dopamine Agonist
• Table 3. Major Manufacturers of Monoamine Oxidase Inhibitors
• Table 4. Major Manufacturers of Acetylcholinesterase Inhibitors
• Table 5. Major Manufacturers of Glutamate Inhibitors
• Table 6. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Parkinson's Disease (PD) Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)
• Table 9. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)
• Table 10. Global Parkinson's Disease (PD) Drugs Sales by Region (2023-2028) & (K Pcs)
• Table 11. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2023-2028)
• Table 12. Global Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 13. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2017-2022)
• Table 14. Global Parkinson's Disease (PD) Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 15. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2023-2028)
• Table 16. Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
• Table 17. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2017-2022)
• Table 18. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 19. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2017-2022)
• Table 20. Parkinson's Disease (PD) Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
• Table 21. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2021)
• Table 23. Parkinson's Disease (PD) Drugs Manufacturing Base Distribution and Headquarters
• Table 24. Manufacturers Parkinson's Disease (PD) Drugs Product Offered
• Table 25. Date of Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 28. Global Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 29. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2017-2022)
• Table 30. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2023-2028)
• Table 31. Global Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 32. Global Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 33. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2017-2022)
• Table 34. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2023-2028)
• Table 35. Parkinson's Disease (PD) Drugs Price by Type (2017-2022) & (USD/Pcs)
• Table 36. Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
• Table 37. Global Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 38. Global Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 39. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2017-2022)
• Table 40. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2023-2028)
• Table 41. Global Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 42. Global Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 43. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2017-2022)
• Table 44. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2023-2028)
• Table 45. Parkinson's Disease (PD) Drugs Price by Application (2017-2022) & (USD/Pcs)
• Table 46. Global Parkinson's Disease (PD) Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
• Table 47. North America Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 48. North America Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 49. North America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 50. North America Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 51. North America Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 52. North America Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 53. North America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 54. North America Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 55. North America Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 56. North America Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 57. North America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 58. North America Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 59. Europe Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 60. Europe Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 61. Europe Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 62. Europe Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 63. Europe Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 64. Europe Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 65. Europe Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 66. Europe Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 67. Europe Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 68. Europe Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 69. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 70. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 71. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 72. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 73. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 74. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 75. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 76. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 77. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 78. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 79. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2017-2022) & (K Pcs)
• Table 80. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2023-2028) & (K Pcs)
• Table 81. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 82. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 83. Latin America Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 84. Latin America Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 85. Latin America Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 86. Latin America Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 87. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 88. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 89. Latin America Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 90. Latin America Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 91. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 92. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 93. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 94. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 95. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2017-2022) & (K Pcs)
• Table 96. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2023-2028) & (K Pcs)
• Table 97. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 98. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 99. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2017-2022) & (K Pcs)
• Table 100. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2023-2028) & (K Pcs)
• Table 101. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 102. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 103. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2017-2022) & (K Pcs)
• Table 104. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2023-2028) & (K Pcs)
• Table 105. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 106. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 107. Boehringer Ingelheim Corporation Information
• Table 108. Boehringer Ingelheim Description and Major Businesses
• Table 109. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 110. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Boehringer Ingelheim Recent Developments
• Table 112. GlaxoSmithKline Corporation Information
• Table 113. GlaxoSmithKline Description and Major Businesses
• Table 114. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 115. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. GlaxoSmithKline Recent Developments
• Table 117. Novartis Corporation Information
• Table 118. Novartis Description and Major Businesses
• Table 119. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 120. Novartis Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Novartis Recent Developments
• Table 122. Teva Pharmaceutical Industries Corporation Information
• Table 123. Teva Pharmaceutical Industries Description and Major Businesses
• Table 124. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 125. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Teva Pharmaceutical Industries Recent Developments
• Table 127. AbbVie Corporation Information
• Table 128. AbbVie Description and Major Businesses
• Table 129. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 130. AbbVie Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. AbbVie Recent Developments
• Table 132. Abital Pharma Corporation Information
• Table 133. Abital Pharma Description and Major Businesses
• Table 134. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 135. Abital Pharma Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Abital Pharma Recent Developments
• Table 137. Addex Therapeutics Corporation Information
• Table 138. Addex Therapeutics Description and Major Businesses
• Table 139. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 140. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Addex Therapeutics Recent Developments
• Table 142. Biogen Corporation Information
• Table 143. Biogen Description and Major Businesses
• Table 144. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 145. Biogen Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Biogen Recent Developments
• Table 147. Eisai Corporation Information
• Table 148. Eisai Description and Major Businesses
• Table 149. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 150. Eisai Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Eisai Recent Developments
• Table 152. Eli Lilly Corporation Information
• Table 153. Eli Lilly Description and Major Businesses
• Table 154. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 155. Eli Lilly Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Eli Lilly Recent Developments
• Table 157. F. Hoffmann-La Roche Corporation Information
• Table 158. F. Hoffmann-La Roche Description and Major Businesses
• Table 159. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 160. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. F. Hoffmann-La Roche Recent Developments
• Table 162. H. Lundbeck Corporation Information
• Table 163. H. Lundbeck Description and Major Businesses
• Table 164. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 165. H. Lundbeck Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. H. Lundbeck Recent Developments
• Table 167. Impax Laboratories Corporation Information
• Table 168. Impax Laboratories Description and Major Businesses
• Table 169. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 170. Impax Laboratories Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 171. Impax Laboratories Recent Developments
• Table 172. Kyowa Hakko Kirin Corporation Information
• Table 173. Kyowa Hakko Kirin Description and Major Businesses
• Table 174. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 175. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 176. Kyowa Hakko Kirin Recent Developments
• Table 177. Otsuka Pharmaceutical Corporation Information
• Table 178. Otsuka Pharmaceutical Description and Major Businesses
• Table 179. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 180. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 181. Otsuka Pharmaceutical Recent Developments
• Table 182. Pfizer Corporation Information
• Table 183. Pfizer Description and Major Businesses
• Table 184. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
• Table 185. Pfizer Parkinson's Disease (PD) Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 186. Pfizer Recent Developments
• Table 187. Key Raw Materials Lists
• Table 188. Raw Materials Key Suppliers Lists
• Table 189. Parkinson's Disease (PD) Drugs Distributors List
• Table 190. Parkinson's Disease (PD) Drugs Customers List
• Table 191. Parkinson's Disease (PD) Drugs Market Trends
• Table 192. Parkinson's Disease (PD) Drugs Market Drivers
• Table 193. Parkinson's Disease (PD) Drugs Market Challenges
• Table 194. Parkinson's Disease (PD) Drugs Market Restraints
• Table 195. Research Programs/Design for This Report
• Table 196. Key Data Information from Secondary Sources
• Table 197. Key Data Information from Primary Sources

List of Figures

• Figure 1. Parkinson's Disease (PD) Drugs Product Picture
• Figure 3. Global Parkinson's Disease (PD) Drugs Market Share by Type in 2021 & 2028
• Figure 3. Dopamine Agonist Product Picture
• Figure 4. Monoamine Oxidase Inhibitors Product Picture
• Figure 5. Acetylcholinesterase Inhibitors Product Picture
• Figure 6. Glutamate Inhibitors Product Picture
• Figure 7. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2021 & 2028
• Figure 8. Hospital
• Figure 9. Family
• Figure 10. Parkinson's Disease (PD) Drugs Report Years Considered
• Figure 11. Global Parkinson's Disease (PD) Drugs Sales 2017-2028 (K Pcs)
• Figure 12. Global Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Parkinson's Disease (PD) Drugs Revenue 2017-2028 (US$ Million)
• Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 15. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2017-2022)
• Figure 16. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2023-2028)
• Figure 17. North America Parkinson's Disease (PD) Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 18. North America Parkinson's Disease (PD) Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 19. Europe Parkinson's Disease (PD) Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 20. Europe Parkinson's Disease (PD) Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 21. Asia-Pacific Parkinson's Disease (PD) Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 22. Asia-Pacific Parkinson's Disease (PD) Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Latin America Parkinson's Disease (PD) Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 24. Latin America Parkinson's Disease (PD) Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Middle East & Africa Parkinson's Disease (PD) Drugs Sales YoY (2017-2028) & (K Pcs)
• Figure 26. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. The Parkinson's Disease (PD) Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 28. The Top 5 and 10 Largest Manufacturers of Parkinson's Disease (PD) Drugs in the World: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2021
• Figure 29. Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 30. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• Figure 31. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• Figure 32. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• Figure 33. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• Figure 34. North America Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• Figure 35. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• Figure 36. North America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• Figure 37. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• Figure 38. North America Parkinson's Disease (PD) Drugs Sales Share by Country (2017-2028)
• Figure 39. North America Parkinson's Disease (PD) Drugs Revenue Share by Country (2017-2028)
• Figure 40. U.S. Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 41. Canada Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 42. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• Figure 43. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• Figure 44. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• Figure 45. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• Figure 46. Europe Parkinson's Disease (PD) Drugs Sales Share by Country (2017-2028)
• Figure 47. Europe Parkinson's Disease (PD) Drugs Revenue Share by Country (2017-2028)
• Figure 48. Germany Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 49. France Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 50. U.K. Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 51. Italy Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 52. Russia Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 53. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• Figure 55. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• Figure 57. Asia Pacific Parkinson's Disease (PD) Drugs Sales Share by Region (2017-2028)
• Figure 58. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Share by Region (2017-2028)
• Figure 59. China Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 60. Japan Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 61. South Korea Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 62. India Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 63. Australia Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. Taiwan Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. Indonesia Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. Thailand Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. Malaysia Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 68. Philippines Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 69. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• Figure 70. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• Figure 71. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• Figure 72. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• Figure 73. Latin America Parkinson's Disease (PD) Drugs Sales Share by Country (2017-2028)
• Figure 74. Latin America Parkinson's Disease (PD) Drugs Revenue Share by Country (2017-2028)
• Figure 75. Mexico Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 76. Brazil Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 77. Argentina Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 78. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2017-2028)
• Figure 80. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2017-2028)
• Figure 82. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Share by Country (2017-2028)
• Figure 83. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Share by Country (2017-2028)
• Figure 84. Turkey Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 85. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 86. UAE Parkinson's Disease (PD) Drugs Revenue (2017-2028) & (US$ Million)
• Figure 87. Parkinson's Disease (PD) Drugs Value Chain
• Figure 88. Parkinson's Disease (PD) Drugs Production Process
• Figure 89. Channels of Distribution
• Figure 90. Distributors Profiles
• Figure 91. Bottom-up and Top-down Approaches for This Report
• Figure 92. Data Triangulation
• Figure 93. Key Executives Interviewed